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Conservative treatments and their limitations
Acute pain, the subjective response to injury, is some-
thing we may be able to comprehend and accept as a
necessary and even welcome signal, to avoid impending
injury and similar encounters in the future. By contrast,
chronic unrelenting pain, divorced from its essential
protective context, becomes a meaningless burden that
can wear down even the stoutest heart. There is nothing
physical to learn from it, and in time, the sufferer is
tired, and in desperation may seek “no matter what kind
of treatment”.
This desperation, shared by the patient as well as the
physician, makes decision-making in pain management
extremely difficult and at times emotional. Many factors
profoundly influence this decision, including the
physician’s attitudes, beliefs, medical cognizance, and
training; the patient’s age, overall health, functional sta-
tus, and ethno-cultural and religious beliefs, as well as
preferences; and also regulatory forces, facilities, and
economic factors [1].
Until recently, opioids were used for pain relief only
in the most desperate of medical conditions, with a cu-
rious, but contextually understandable dichotomy to-
wards pain of malignant versus nonmalignant origin [2].
Contemporary approaches to managing pain emphasize
earlier and more liberal use of opioids, citing a low
potential for addiction and an overall favorable risk-
benefit ratio. However, while there is reasonable scien-
tific support for this general contention, in practice,
symptom control remains completely empirical.
The role of minimally invasive and anesthetic pain-
relieving modalities is even more ill defined, creating a
situation analogous to that with opioids. Although there
is fairly widespread agreement that procedures have
a favorable risk-benefit ratio, no uniformly accepted
validated methods have been devised to prospectively
determine in what settings which procedures are
valuable.
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Introduction
Alleviating pain is not a recent concern. All know that
intense chronic pain has a profound, distressing influ-
ence on a person’s physical and mental wellbeing. Be-
cause pain is the most common disabling disease, it
imposes severe economic stresses on the patient and
society; thus, it constitutes serious national and world
health problems. But it is only in treating the patient as
a person, rather than as a passive receptacle, that the
role of interventional pain management has begun to
advance.
Interventional pain management offers a spectrum of
minimally invasive procedures, with both diagnostic
and therapeutic intent, for patients suffering from
chronic, persistent, and intense pain. Patients with mul-
tiple back surgeries, endstage cancer, and neuropathic,
ischemic, and central pain now have hope, and as we
move into the twenty-first century with improved tech-
nologies borrowed from many disciplines, we are clos-
ing the gaps in our knowledge that were conferred by
scientific ignorance. Neuromodulation, novel drugs with
novel drug delivery systems, and even gene therapy are
all out there on the horizon.
Deficiencies in pain management still exist, but pain
medicine is rapidly approaching responsibility and rec-
ognition, and we hope that, in time, pain medicine will
become an independent specialty. Nevertheless, the
days of the omnipotent, omnipresent physician who
“waves his hand” over a silent, awestruck patient are
over.
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Nevertheless, the use of interventional pain manage-
ment techniques has grown exponentially, and with this
has come a better understanding of what can and cannot
be expected from these procedures. It is beyond the
scope of this review to explain the multitude of mini-
mally invasive procedures for all refractory pain syn-
dromes; thus, we shall focus on the basics: patient
selection, procedure selection, and outcomes known to
date in the literature.
Patient selection
The cornerstone of patient selection is an accurate
pain diagnosis, avoiding exclusion diagnoses such as
fibromyalgia, psychogenic pain, somatization disorder,
and malingering, while creating a bond of trust with the
patient, which later will be essential in pursuing a thera-
peutic program. Patient selection criteria for most
interventional procedures are shown in Table 1.
Confounding this already difficult picture is the pres-
ence of variables that may adversely directly or indi-
rectly influence outcome. Motivation is the first and
foremost important variable that affects procedure
results. Patients with secondary gain issues, litigation, or
a desire to be relieved of social responsibilities will
probably not do well, even with a perfectly executed
technique. Low compliance history with previously pre-
scribed treatment regimens and chemical dependency
on opioids, benzodiazepines, and barbiturates are noto-
riously known to be difficult to manage. Finally, there is
a correlation between educational level and ultimate
outcome, due in part to the presence of poor coping
strategies, no return-to-work incentive, and lack of
comprehension of procedure outcome [3]. Other nega-
tive predictors include the chronicity of pain, the pres-
ence of comorbidities such as diabetes, osteoporosis,
peripheral vascular disease, and others, and poor opera-
tor skills.
Patient selection is best done by a team approach,
thus addressing medical, interventional, psychological,
and vocational aspects of the proposed therapeutic
scheme. One must bear in mind that, with certain proce-
dures (spinal cord stimulators, intrathecal pumps,
epidural port-a-cath’s, Deltec, St. Paul, MN, USA)
therapeutic relationships between the patient and the
interventionist will persist, perhaps throughout life, and
regular communication and surveillance is essential.
Procedure selection
What to do with refractory back pain?
Disabling low back pain is a significant and common
medical problem in the Western world, affecting mil-
lions of people annually. Back pain is reported as the
second leading symptom resulting in physician visits in
the United States and Europe, and estimates of direct
medical costs are staggering. Ninety percent of adults
experience low back pain during their lifetime, although
resolution of symptoms occurs with non-specific treat-
ments in 75%–90% of patients. It is estimated that the
remaining 10% of refractory patients account for 80%
of the overall cost of back problems. In patients under
the age of 45, low back pain results in more disability
than any other health problem, and overall is second
only to the common cold in incidence [4].
Many guidelines exist regarding the treatment of low
back pain [5]. Regardless of its etiology (e.g., herniated
nucleus pulposus, internal disc disruption, degenerative
disc disease, facet syndrome, myofascial pain syndrome,
ligamentous strain, tumor, vertebral compression frac-
tures, and spinal stenosis), it is clear that failure of con-
servative treatment for more than 4 weeks merits an
interdisciplinary approach, which includes medical, sur-
gical, interventional, and psychological analysis.
From an interventional point of view, there are sev-
eral key questions that construct the rationale of the
treatment algorithm (Table 2).
As we can see, “back pain” includes a multitude of
different cases. A middle-aged patient suffering from
low back pain after lifting a heavy load, without clear
radicular signs or conclusive imaging findings, is differ-
ent from a young patient suffering from persistent leg
pain after two herniated disc operations associated with
the presence of postoperative fibrosis, which is different
from an elderly patient suffering from back and leg
pain associated with activity, with diffuse degenerative
changes shown on imaging.
Diagnosis is essential, and interventional pain tech-
niques are minimally invasive procedures that have
diagnostic as well as therapeutic value. They do not
Table 1. Patient selection criteria
1. Pain refractory to all previous conservative treatments
2. Pain responsive, but accompanied by an intolerable side-
effect profile
3. Patient understands and accepts treatment
4. No coagulopathy or infection
5. No major psychopathology
Table 2. Key questions to be asked prior to treatment
1. Is the patient suffering from back pain? leg pain? both?
2. Is the pain mostly nociceptive? neuropathic? mixed?
3. Are there signs of true or pseudoradiculopathy?
4. Can the imaging findings explain the pain?
5. Has the back been operated upon?
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replace surgery when indicated, or medical treatment
when efficient. These are complementary procedures,
which, on one hand, may increase the sensitivity and
specificity of certain tests (e.g., selective nerve root
blocks, discography, epiduroscopy), and they may also
assist in persistent pain syndromes where medication
side effects (mostly those of nonsteroidal anti-
inflammatory drugs [NSAIDS] and opioids) are unwar-
ranted or intolerable (e.g., cortisone infiltration,
radiofrequency [RF] lesioning).
When pain persists, despite an unrevealing workup,
and inflammatory, metabolic, and tumor etiologies have
been excluded one must determine whether this is back
pain with or without painful radiculopathy (Fig. 1).
As one can see, back pain with no, or with
pseudoradiculopathy usually emanates from three main
etiologies. Pure facet arthropathy (also known as facet
syndrome) is the sole etiology in only 15%–20% of
chronic low-back-pain patients, but, when it exists,
treatment by RF lesioning is efficacious [6]. The
rationale for the application of RF denervation is the
assumption that the selective heating of nervous struc-
tures can impede nociceptive input. Practically, this is
achieved by the percutaneous application of a small-size
electrode at target neural tissues, resulting in size-
controlled lesions at different anatomical positions (Fig.
2).
RF lesioning is always preceded by two to three diag-
nostic blocks done under fluoroscopic control with a
minute amount of local anesthetic to make sure that
there is no placebo response to the procedure. If re-
sponses to diagnostic blocks are unequivocal, a defini-
tive treatment is offered, with an effect that usually lasts
between 12 and 18 months, and the treatment can be
repeated regularly. Other sites, such as the sacroiliac
joint, seem responsive to treatment, and RF lesioning
offers a promising therapeutic alternative [7] (Fig. 3).
Disc disease, however, is much more complex in
nature and involves multiple pain targets, such as
posterior annulus nociceptors, segmental dorsal root
ganglions, and sympathetic chain and segmental nerve
roots when the disc is compressed. It is therefore diffi-
cult to think of one “magical” infiltration in these cases,
with an absolute therapeutic effect. However, in pa-
tients who are not candidates for surgery (no frank
neural deficit, absence of sequestered disc, no segmen-
tal instability), RF lesioning of the disc may offer a
therapeutic alternative [8].
Intradiscal electrotherapy (IDET) is a percutaneous
procedure using RF as a heat source which induces
collagen changes within the disc, which, in turn, can
decrease disc protrusion, as well as producing nocicep-
Fig. 1. Back pain algorithm. IDET,
intradiscal electrotherapy
Fig. 2. Median branch block for the diagnosis of low back pain
suspected to originate from the zygapophysial (facet) joint
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tor denervation of the posterior annulus due to the
heating effect. IDET is always preceded by a diagnostic
discography, and its effects, after appropriate rehabili-
tation, last for years (Fig. 4).
When radicular pain is suspected, another approach
is employed (Fig. 5).
In radicular pain it is essential to differentiate be-
tween operated backs (also known as failed back sur-
gery syndrome [FBSS]), versus nonoperated backs,
because a suspicion of the presence of epidural fibrosis
alters the therapeutic yield of injections [9].
Conflicting studies over the past 40 years have been
reported on the efficacy of lumbar epidural steroids in
patients with radicular pain [10]. Despite the controver-
sies, these injections are frequently performed and most
practitioners feel strongly that patients do derive a sig-
nificant benefit. Yet, all acknowledge that some patients
receiving steroid injections do not improve, perhaps due
to poor patient selection, misdiagnosis, and inappropri-
ately administered or misplaced injections.
If the effect of epidural steroid injections is local, i.e.,
a direct effect on the injured nerve root, then it is essen-
tial that the steroid reaches the site of injury. Histori-
cally, epidural steroid injections have been performed
“blindly”, without any radiological guidance. Many fac-
tors may prevent the steroid from reaching the intended
nerve root, including scarring, adhesions, and epidural
adipose tissue and septa, which may be present both in
the patient who has undergone previous lumbar spine
surgery and in the patient who has never had back
surgery [11].
In the presence of epidural fibrosis, drugs injected
will follow the path of least resistance. Theoretically,
this will divert the drug away from the painful nerve
associated with the fibrotic material. This supports the
clinical observation that many patients report signifi-
cant relief after one injection but not after another. It is
thus essential that any instillation of medication be site-
specific under fluoroscopic control.
Epidural neuroplasty (also known as the Racz proce-
dure) [12] consists of accessing the epidural space in
the caudal or transforaminal approach, and injecting
nonionic contrast material (thus performing an
epidurogram) in order to detect “filling defects”. This is
followed by the gentle manipulation of a metal rein-
forced catheter in order to liberate adhesions (“filling
the defects”), and then by the injection of the targeted
medication. This procedure, which allows prolonged
pain relief in refractory cases, has the advantage of tar-
geted drug delivery, but has the disadvantage of indi-
Fig. 3. Sacroiliac joint block for the diagnosis of low back pain
suspected to originate from the sacroiliac joint
Fig. 4. Intradiscal electrotherapy (IDET) for the treatment of
low back pain from a painful disc
Fig. 5. Leg pain algorithm
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rect, two-dimensional vision of the presumed pathology
(Fig. 6).
With the advent of the use of endoscopic technology
in pain medicine, epiduroscopy has been introduced. In
essence, this procedure includes the insertion of a fine
fiberoptic endoscope via the caudal hiatus, under fluo-
roscopic control, to the presumed level of pathology.
Epidural structures and nerve roots are directly visual-
ized, and the presence of inflammation and fibrosis is
noted. The procedure is done under local anesthesia,
while continuously monitoring the intra-epidural pres-
sure, and the patient’s response. Normal nerve roots,
when touched, cause paresthesia, but diseased ones
hurt, so the patient’s report is essential while the opera-
tor gently performs adhesiolysis. Recent results are
promising [13], and the future association with intra-
operative nerve stimulating is exciting.
When radiculopathy is refractory or without the clear
presence of fibrosis, a second approach may be used
(Fig. 7).
Again, selective nerve root injections that are either
diagnostic or therapeutic in nature are warranted; how-
ever, a more imaginative approach must be used.
Neuropathic pain is usually considered to be a con-
traindication for the use of RF lesioning, because it
makes little sense to perform a neurodestructive proce-
dure in the presence of altered neural function, as this
risks aggravating the neural pathology (i.e., deafferen-
tation pain, neural damage). However, pulsed RF
(PRF), where short bursts of RF energy are applied to
the nerve, is thought to be a safer alternative to classical
RF, and to date there is no clinical evidence of neural
damage [14]. The mechanism by which PRF works re-
mains unclear. Some studies suggest that the analgesic
effect is a neuromodulatory rather than a neuro-
destructive one [15].
PRF is basically performed exactly like thermal RF,
with an apparatus capable of transmitting the appropri-
ate energy. The field of PRF opens new horizons to
other treatments of neuropathic pain syndrome, such as
postherpetic neuralgia, frozen shoulder, intercostal neu-
ralgia, complex regional pain syndrome (CRPS) type I,
and more.
Finally, “when all else failed” and the pain persists,
the utilization of implantable devices (such as spinal
cord stimulators and implantable pumps) comes into
place (Fig. 8).
What to do with refractory cancer pain?
Surprisingly enough, the treatment of refractory cancer
pain is much simpler and more straightforward than the
treatment of back pain. Perhaps because the etiologies
of cancer pain are less enigmatic than those of back
pain, perhaps we feel more comfortable in introducing
invasive procedures in dire situations, or perhaps we
feel ethically obliged “to do something” in cancer pain,
Fig. 6. Percutaneous neuroplasty for the treatment of persist-
ent low back and leg pain from a nerve root fibrosis
Fig. 7. Refractory leg pain algorithm
Fig. 8. Implantable device algorithm
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Fig. 9. WHO analgesic ladder
Fig. 10. Pain control continuum. OTC, over-the-counter
which is regarded as a more “acceptable and under-
stood” type of pain.
Eighty to ninety percent of cancer patients respond to
the WHO analgesic ladder (Fig. 9) when it is appropri-
ately used [16]. However, 10%–20% do not respond.
This is not a negligible number, and it is imperative that
physicians do not give up seeking alternative pain-
control techniques. All too often physicians rely only on
familiar therapies, even when these fail to control pain,
and patients pass the last weeks of their lives in unnec-
essary suffering. This need not be.
Available therapies include epidural or intrathecal
drug delivery systems (such as port-a-cath, or com-
pletely internalized systems), neurolytic (also known as
neuroablative) procedures (such as alcohol neurolysis),
and neurosurgical procedures (e.g., cordotomy,
myelotomy) (Fig. 10).
Whatever the treatment, the patient selection criteria
remain the same (Table 1). Decision on implanting an
external versus internal, or an intrathecal versus epidu-
ral system depends on the patient’s general status, life
expectancy, and technical support availability [17].
Roughly speaking, patients with thoraco-abdominal or
lower limb pain with a life expectancy of between 3 and
12 months will do well with an epidural port-a-cath
system, while patients with metastatic diffuse pain
should have either partially or completely internalized
intrathecal systems.
All implantations are preceded by a diagnostic trial,
and those who are responsive are considered for a
definitive treatment (Fig. 11). Different medications
(mostly morphine) have been proposed.
As for spinal cord stimulation, it is used as a
neuromodulatory tool in cases of refractory neuro-
pathic pain (CRPS type I, phantom pain, postherpetic
neuralgia); ischemic pain (refractory angina, peripheral
vascular disease); mixed pain (failed back surgery syn-
drome); or cancer pain [18,19]. The implantation of
temporary electrodes in the epidural space precedes the
implantation of a permanent generator (Fig. 12). A trial
period, varying between 3 days and 3 weeks, discloses
the patient’s response to this treatment. Once decided
upon, the pacemaker is internalized in the abdominal
wall (usually the left lower quadrant) or the buttocks,
Fig. 11. Pump implantation algorithm
Fig. 12. Spinal cord stimulator algorithm
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and further follow-up is similar to that of a patient with
a cardiac pacemaker.
Conclusions
It is important to remember that all medical interven-
tions are associated with risks and benefits, which com-
promise the famous risk-benefit ratio. All interventions
have alternatives (including no intervention), and each
alternative possesses its own risk-benefit ratio. Thus,
clinical decision-making involves comparing and con-
trasting the risk-benefit ratio not only of the procedure,
but of the alternative intervention as well.
In this short review we have not discussed many other
important interventional modalities, such as cryo-anal-
gesia, vertebroplasty, and kyphoplasty, and various so-
matic and sympathetic blocks. It is not our aim to recall
an exhaustive list of theoretical procedures, but, rather,
to remind us that pain medicine in general, and
interventional pain medicine in particular, have re-
cently emerged as a lively and dynamic subspecialty,
with ever-changing techniques and approaches develop-
ing before our very eyes.
Debate over the role of invasive procedures for
chronic pain will probably rest for a while, evoking
strong emotions similar to those evoked during the
“opioid phobia” era in the 1980s. Be that as it may,
there is an agreement that outcomes for procedures are
most salutary when they are properly integrated into a
multidisciplinary matrix. But this contention demands
collaboration, collegial discussion, and praise for inno-
vation and open horizons. Evidence-based medicine is
but a tool to drive us to create our own evidence and not
to rest passively back and wait for it to come.
Our moral obligation dictates not just “to do no
harm”, but to do “good” as well [20].
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